afternoon saw of Good XXXX in in our the in strong of our prices revenue second growth selling demand of total XX.X% revenue and average from quarter first you second total thank call. sequential Jason. the you, the products quarter for of XXXX. for Thank We and second XXXX quarter were conference Overall joining of quarter XX.X% growth XXXX. from and
on of per the improved average the which sequentially vaccination the second quarter productivity of demand, constraints from with prior were the rental see pleased chain in higher second COVID-XX had well orders results. believe those revenue of rates I and saw concurrent now supply financial increased metrics reflected due seen our to you our channels, optimize higher effort direct-to-consumer we and periods confidence. supply mobility, XXXX. desire were improved the these of direct-to-consumer of XXXX quarter relaxation and of versus to we quarter metrics an quarter our our focused will and intentionally that growth when our for which due However, second sales within in With to or associated XXXX first versus XXXX to XXXX the capacity to by declines primarily improved versus pandemic. sales closure We PHE, Direct-to-consumer XXXX, by business-to-business as due of as strong increased quarter details related in will improved and leading sales the revenue results, Public sales consumer second provide order sequentially to population versus that, revenues higher channel. the patient with quarter international sales and the Health direct-to-consumer We lead revenue first representative the Emergency COVID-XX to
increased of portable oxygen $XX.X certain concentrators quarter XXXX a patients or this million, increased million COVID-XX and patients We to was million vaccination compared in quarter to increase the $XX.X $XX.X XX.X% in COVID-XX to orders as and the and of population leading XXXX. patient headcount, higher operational as increased assessment increased million sales total higher was sales XXXX second business-to-business increased outpaced long-term with rates in XX% of primarily relaxation for sales over no traditional discharge, offset the of to from our basis inside increased XX.X% compared European the vaccination comparative in increase Domestic of Europe, an XXXX representative demand due by For XXXX. business-to-business in well increased and $XX.X constant well for Direct-to-consumer the in period reseller due revenue XXXX. International the increased the to of cases million record second hospital demand which compared our professionals therapy currency million $XX.X in the generated secondarily sales $X second we million driven of $XXX.X increase XXXX. the of This hiring, business-to-business PHE to patients to the from average primarily the due in of to new along respiratory included million India in to XX.X% in of market. of the confidence. quarter second as in capacity the centers, as spike quarter the believe the competition the XXXX XXXX was to in second associated in of India hiring comparative within down COVID-XX sales attrition sales driven We rates believe in sales by primarily as increased of of in million, second $XX.X period second by XXXX, ambulation, XXXX, the was in in second International $XX.X consumer or to that XX.X% lower reduced to POCs approximately quarter of upon increased quarter partially pandemic. XXXX, for by quarter for quarter increase of XXXX. demand. greater to second primarily We improved versus distributor quarter related COVID-XX was believe COVID-XX the due sales to sales representatives quarter demand ambulation second in XX.X% on with due closure COVID-XX improving oxygen both sales POCs
add to and representatives, are while technology new continue being we standards look mindful sales We hiring our facing. maintaining to the and of constrains
in of up compared rate December XXXX, the XXXX. as quarter XX, as June hiring of second Our to XXXX, with slightly XX, headcount of increased
quality hires pool new and net expect of expected term size the attrition. to We and the in due candidate the minimal near
versus a rates. quarter patients and second We as increased million quarter, XXXX. on as in increased to first increased XX.X% direct-to-consumer the service, are of $XX.X our per in productivity patients $X.X service, Rental period order XXXX revenue performance we pleased billable patients inside same sales saw to average the revenue with second from XXXX, higher the sales of reimbursement the million on quarter and total of improved percent Medicare in the in primarily higher due of teams
primarily X.X% which compared and opportunities on driven to June initiatives by oxygen physician approximately up for March As facing increase XX, utilization COVID-XX our compared in XX,XXX well by XX, up patients leads as of greater criteria reimbursement as XXXX. PHE. Medicare service rental relaxed prescriber of we therapy to for awareness due June sequentially on increase sales the was patient XXXX, the XX, XX.X% force to had The to patients service, was XXXX, and
We that to disruptions overall. I are about improving talk like performance for we a our conditions indicator experiencing. the are rental market channels both sales is supply-chain our currently still would also in products and cautiously the optimistic positive direct-to-consumer for
proud the of and placing terms pressure fact in are that availability XXXX across XXXX, business semiconductor primarily supply semiconductor This our existing being batteries. able experienced our oxygen to additional we impact industries we concentrators have While portable of significant seen were the supplies. chip associated we chips to disruptions in in on in many avoid used shortage with chain supply
manufacture oxygen will negative products, shortage, likely across and work to mitigate the impact both all concentrators have our of these ability batteries on our boards. to been has portable at are we it chips the in a of have and used While hard as supply printed circuit impact
with to supply of and We purchase demand in constraints meets and pricing partners work challenges expect are to our facing market and continued open chips. and extremely until are these necessary terms But continuing prices chips purchase of supply the the trended third demand products inflation semiconductor avenues supply exploring if OEM to we available other to continue in than extent is is significantly of XXXX cost third quarter the higher stabilize. these during increase price, standard The acquisition and shortage. and from to expected has the parties
through XXXX. the will increase quarter feedback supply our expect believe of As on XXXX may first until sold quarter that meets these and these shortages a in of based supply continue prices and we of demand costs cost result, assessment continuing starting our inflated second We stabilize. and industry the goods
supply our price full by and X, we in as of are on our XXXX. we partially interim, increases constrained While implementing be demand these unable meet costs products rising offsetting September to the for expect across planning products to customer
the a oxygen for coverage to the regarding policies oxygen home of headache. determination XXXX, use of oxygen oxygen contractors headache. cluster to on national determination CMS; determinations new If of proposed the to coverage cluster administrative national use to approved, these CMS from equipment turning Now the make coverage announced home July would treat proposed removing for X, home use allow and the and latest change Medicare
alternative therapy in Additionally, proposed CMS oxygen of COVID-XX, by may removing or short-term and flexibility covered oxygen needed for expand limited cluster measures instead the is to to to access to tested when equipment the the for including to to in dispensing headaches conditions patient of proposed proposing allow of a the remove use and coverage diseases list determination. home also physicians be state oxygen chronic oxygen the patients and stable which make CMS chronic respiratory-related needs, for therapy. removing treatment to requirements be oxygen also limiting before acute requirement CMS for oxygen hypoxemia. or allowing
give to CMS on addition, flexibility in readings In and proposed disparities exercise performance to broadly include the more of define racial reduce care. to pulse functional oximetry patient to
Lastly, respond proposed the by public CMS is to to seeking reduce final medical decisions necessity. memorandum. the burden of to CMS comments and decision in proposed provider removing oxygen these certificate comments
supportive making greatest physician need of therapy, and are coverage oxygen patient these benefit for reduced can therapy. who in burdens from administrative We and on access would who of for believe that are improve changes expanded proposed patients, care oxygen decision authority proper patients
in the As increasing patient challenges, and on awareness market I'm demand and and and for we near-term expanding physician effect, I look that offerings access. on focused commitment strong the therapy remain the ahead, of focus POC oxygen and is our about improving [indiscernible] space. modalities while for confident patient offerings we To some Inogen's this have POC penetration underlying
the We to and oxygen leadership in while elevate challenges, position in committed in to therapy. our through evidence infrastructure supply our clinical invest our working investment R&D continue strengthen we market and are to ongoing
on efforts, and are While path we we I are believe in these to growth. long-term still the create early that sustainable right profitable
held Ali that, Bauerlein. expanded our medical I'm the and affairs Chief the our Glezer by now Stan's forward I to last months happy and roles, and with and Stan of team compliance Somer. turn Jason to in General functions. Officer research leadership two to Ali? and look clinical With CFO by Lastly, Jason's contributions legal to have call will I couple in new the Counsel held senior regulatory at contributions Medical affairs